뒤로
Northwest Biotherapeutics Inc(NWBO) 가격
NWBO 주가 차트
NWBO 수입
Northwest Biotherapeutics Inc
$0.3
5.93%
$0.01
종가: Jan 16, 16:00:00 GMT-5
$0.3
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$0.2832
시가
$0.2898
일일 범위
$0.2826 - $0.301
52주 범위
$0.17 - $0.48
거래량
1.5M
평균 거래량
3.8M
EPS(TTM)
-0.06
배당수익률
--
시가총액
$458.6M
NWBO란 무엇인가요?
Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. The company is headquartered in Bethesda, Maryland and currently employs 25 full-time employees. The company went IPO on 2001-12-14. The firm is focused on developing personalized immune therapies for cancer. The company has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The firm's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. The company has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and includes treatment of a diverse range of more than a dozen types of cancers. Its subsidiaries include Flaskworks LLC, NW Bio GmbH, Northwest Biotherapeutics Capital Limited, Northwest Biotherapeutics B.V., Advent BioServices Ltd., and others.